Askoxylakis V - Search Results

1

Peptide arrays for development of PDGFRβ Affine molecules.

Marr A, Nissen F, Maisch D, Altmann A, Rana S, Debus J, Huber PE, Haberkorn U, Askoxylakis V. Marr A, et al. Among authors: askoxylakis v. Mol Imaging Biol. 2013 Aug;15(4):391-400. doi: 10.1007/s11307-013-0616-0. Mol Imaging Biol. 2013. PMID: 23381728

2

Optimization of a novel peptide ligand targeting human carbonic anhydrase IX.

Rana S, Nissen F, Marr A, Markert A, Altmann A, Mier W, Debus J, Haberkorn U, Askoxylakis V. Rana S, et al. Among authors: askoxylakis v. PLoS One. 2012;7(5):e38279. doi: 10.1371/journal.pone.0038279. Epub 2012 May 31. PLoS One. 2012. PMID: 22693612 Free PMC article.

3

Peptide-based targeting of the platelet-derived growth factor receptor beta.

Askoxylakis V, Marr A, Altmann A, Markert A, Mier W, Debus J, Huber PE, Haberkorn U. Askoxylakis V, et al. Mol Imaging Biol. 2013 Apr;15(2):212-21. doi: 10.1007/s11307-012-0578-7. Mol Imaging Biol. 2013. PMID: 22791264 Free PMC article.

4

A new prostate carcinoma binding peptide (DUP-1) for tumor imaging and therapy.

Zitzmann S, Mier W, Schad A, Kinscherf R, Askoxylakis V, Krämer S, Altmann A, Eisenhut M, Haberkorn U. Zitzmann S, et al. Among authors: askoxylakis v. Clin Cancer Res. 2005 Jan 1;11(1):139-46. Clin Cancer Res. 2005. PMID: 15671538

5

Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275.

Altmann A, Eisenhut M, Bauder-Wüst U, Markert A, Askoxylakis V, Hess-Stumpp H, Haberkorn U. Altmann A, et al. Among authors: askoxylakis v. Eur J Nucl Med Mol Imaging. 2010 Dec;37(12):2286-97. doi: 10.1007/s00259-010-1573-3. Epub 2010 Aug 3. Eur J Nucl Med Mol Imaging. 2010. PMID: 20680269

6

A new peptide ligand for targeting human carbonic anhydrase IX, identified through the phage display technology.

Askoxylakis V, Garcia-Boy R, Rana S, Krämer S, Hebling U, Mier W, Altmann A, Markert A, Debus J, Haberkorn U. Askoxylakis V, et al. PLoS One. 2010 Dec 31;5(12):e15962. doi: 10.1371/journal.pone.0015962. PLoS One. 2010. PMID: 21209841 Free PMC article.

7

Challenges in optimizing a prostate carcinoma binding peptide, identified through the phage display technology.

Askoxylakis V, Zitzmann-Kolbe S, Zoller F, Altmann A, Markert A, Rana S, Marr A, Mier W, Debus J, Haberkorn U. Askoxylakis V, et al. Molecules. 2011 Feb 14;16(2):1559-78. doi: 10.3390/molecules16021559. Molecules. 2011. PMID: 21321528 Free PMC article.

8

Investigation of tumor hypoxia using a two-enzyme system for in vitro generation of oxygen deficiency.

Askoxylakis V, Millonig G, Wirkner U, Schwager C, Rana S, Altmann A, Haberkorn U, Debus J, Mueller S, Huber PE. Askoxylakis V, et al. Radiat Oncol. 2011 Apr 10;6:35. doi: 10.1186/1748-717X-6-35. Radiat Oncol. 2011. PMID: 21477371 Free PMC article.

9

Biotechnology techniques for the development of new tumor specific peptides.

Marr A, Markert A, Altmann A, Askoxylakis V, Haberkorn U. Marr A, et al. Among authors: askoxylakis v. Methods. 2011 Nov;55(3):215-22. doi: 10.1016/j.ymeth.2011.05.002. Epub 2011 May 27. Methods. 2011. PMID: 21640826 Review.

10

Combination of phage display and molecular grafting generates highly specific tumor-targeting miniproteins.

Zoller F, Markert A, Barthe P, Zhao W, Weichert W, Askoxylakis V, Altmann A, Mier W, Haberkorn U. Zoller F, et al. Among authors: askoxylakis v. Angew Chem Int Ed Engl. 2012 Dec 21;51(52):13136-9. doi: 10.1002/anie.201203857. Epub 2012 Nov 13. Angew Chem Int Ed Engl. 2012. PMID: 23150222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters